We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and ranking member Ron Wyden (D-Ore.) have updated their bipartisan drug pricing legislation with provisions to reduce out-of-pocket expenses — and President Trump has said he would sign it into law. Read More
Four high-ranking House Republicans introduced drug pricing legislation Monday designed to replace House Speaker Nancy Pelosi’s H.R. 3, a bill they dismissed as one-sided and doomed to fail. Read More
The agency warned sponsors that recent technological innovations make it easy for other parties to easily deduce a patient’s identity from deidentified trial data. Read More
Acting FDA Commissioner Brett Giroir said the biosimilar and interchangeable insulin products should increase access and reduce costs of insulin products. Read More
The FDA handed the medication breakthrough therapy, fast track, orphan drug, and rare pediatric disease designations, as well as priority review. Read More